International Activity Report 2005 Uzbekistan
International Staff: 13
National Staff: 130
Helping patients with
resistant TB
In Uzbekistan's Karakalpakstan region, near
the shrunken Aral Sea, the harsh environment
and lack of health care services have
caused severe health problems. While
tuberculosis (TB) has long been a scourge,
irrational medicine use and long treatment
regimes have increased the number of
people now resistant to the drugs used for
first-line treatment. Today, Karakalpakstan's
1.5 million residents have one of the highest
incidences of multidrug-resistant TB
(MDR-TB) in the world. Currently, 13 percent
of all new TB patients and 40 percent
of those needing treatment again suffer
from multidrug-resistant TB strains.
MSF works in the city of Nukus to treat
people living with MDR-TB. The treatment
is demanding. To kill the bacilli that cause
the disease, patients must take medicines
that can have serious side effects, for 18 to
24 months. The long regimen is difficult to
follow fully for many patients, especially
those who move often, are homeless or are
the main providers for their families.
Through this project, MSF is seeking to
demonstrate that non-wealthy countries
such as Uzbekistan can conduct complex
treatment programs. In cooperation with
the ministry of health, MSF runs the 60-bed
TB Hospital #2, which was established to
treat patients in the first phase of MDR-TB.
During the early phase, patients are at their
most infectious and require intensive inpatient
treatment. MSF and the ministry also
work together in a number of specialized
medical clinics that treat patients in the
second treatment phase. In this later
phase, patients can be treated on an outpatient
basis, with careful monitoring.
To
prepare the hospital to facilitate their care,
MSF rebuilt its outpatient polyclinics and a
specialized laboratory. The team has also
trained hospital personnel. In 2004,
approximately 100 patients were under
treatment through this program. In May
2005, after 18 months of treatment, the
first two patients were declared cured.
MSF has worked in Uzbekistan since 1997.
Table of
Contents
The Year in Review Rowan Gilles, M.D., President, MSF International Council Marine Buissonnière, MSF Secretary-General
Malaria: MSF's constant challenge By Christa Hook, Head of MSF's International Working Group on Malaria
and Nathan Ford, Director of MSF's Manson Unit which provides support to malaria field programs